How good is it? * indicates the important links in the menu. The analysis is useful for short term traders who trade stocks with technical anlaysis. This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. View real-time stock prices and stock quotes for a full financial overview. A "buy" rating indicates that analysts believe XCUR will outperform the market and that investors should add to their positions of … Their average twelve-month price target is $9.60, predicting that the stock has a possible upside of 291.84%. Investment Research, Inc, licensed by Zacks Investment Research, Inc. from The sector with the worst average Zacks Rank (16 out of 16) would place in the bottom 1%. Is Exicure Stock a good buy in 2021, according to Wall Street analysts? If you do not, click Cancel. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Neither Zacks Investment Fortress Biotech stock price ended on $4.18 on Tuesday after losing 2.34% (Updated on March 16, 2021) Buy or Hold candidate since 2021-02-01 Gain 26.28% PDF The Fortress Biotech stock price fell by -2.34% on the last day (Tuesday, 16th Mar 2021) from $4.28 to $4.18. Find the latest Exicure, Inc. (XCUR) stock quote, history, news and other vital information to help you with your stock trading and investing. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%. They use their proprietary Smart Scan and Trade Triangle technology to analyze the stock and you will get an instant report on how XCUR will perform in the near future. ... and a bulleted list of reasons to buy or sell the stock. The high price target for XCUR is $18.00 and the low price target for XCUR is $6.00. 2.4400 -0.01 (-0.41%)After hours: 7:49PM EDT, Subscribe to Premium to view Fair Value for XCUR. Learn about XCUR (XNAS) with our data and independent analysis including price, star rating, valuation, dividends, and financials. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. XCUR closed down 0.48 percent on Friday, March 5, 2021, on 1.53 times normal volume. Bullish Indicators Bearish Indicators Delayed quotes by Sungard. To keep the results in a more logical format, we factor the overall opinion by 1.04 to keep the end result in multiples of 8 percentage points, with the exception of a … Should I buy Exicure, Inc. (XCUR)? As the shares of Textron and other defense contractors recover to pre-Covid levels, the shares of Axon Enterprise, manufacturer of the popular … All rights reserved. Information Providers, or gathered by Zacks Investment Research, Inc. from This is an estimated date of earnings release. The company traded as low as $2.35 and last traded at $2.36. Exicure, Inc. (NASDAQ:XCUR) fell 7.1% on Thursday . XCUR Stock Predictions. However, rules govern insider transactions, and certain disclosures are required. ... Is XCUR A Good Stock To Buy Now? Click here to watch the full series. There is a sell signal from a pivot top found 3 day(s) ago.) XCUR Technical Analysis. If you are looking for stocks with good return, Exicure Inc stock can be a bad, high-risk 1-year investment option. Exicure Inc (XCUR) stock has fallen -7.5% while the S&P 500 has gained 0.66% as of 2:45 PM on Wednesday, Jan 8. The sector with the best average Zacks Rank would be considered the top sector (1 out of 16), which would place it in the top 1% of Zacks Ranked Sectors. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. Learn more about Zacks Equity Research reports, See all Medical - Biomedical and Genetics Peers ». Stay up to date with Exicure Inc stock news. There are currently 5 buy ratings for the stock. Visit Performance Disclosure for information about the performance numbers displayed above. See Zacks' prediction free. Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F. As an investor, you want to buy stocks with the highest probability of success. Exicure Inc real time quote is equal to 2.595 USD at 2021-03-17, but your current investment may be devalued in the future. The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. publicly available sources. Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank, Industry: Medical - Biomedical and Genetics. Analyst Report: Bristol-Myers Squibb Company, Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqCM - NasdaqCM Real Time Price. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Post-Market 0.00 (0.00%) The consensus among 2 Wall Street analysts covering ( NASDAQ : XCUR ) stock is to Strong Buy XCUR stock. the Web site, including, but not limited to Information originated by Zacks Analyst Price Target for XCUR i $ 10.50 ... ARN does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. Exicure Inc (NASDAQ:XCUR) Real-Time Quotes. Stock screener for investors and traders, financial visualizations. Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. Zacks Rank Education - Learn about the Zacks Rank, Zacks Rank Home - Zacks Rank resources in one place, Zacks Premium - The only way to fully access the Zacks Rank. Zacks Rank Education -- Learn more about the Zacks Rank
Wayfair is benefiting from a growing millennial population, which will lead to rising housing sales. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. © 2021 Verizon Media. Get the latest Exicure, Inc. XCUR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Get Wall Street analysts ratings for Exicure, Inc. (XCUR). Buy or Sell this stock? . . The scores are based on the trading styles of Value, Growth, and Momentum. XCUR is trading in the range of $1.93 - $2.83 in the past 30 days. NYSE and AMEX data is at least 20 minutes delayed. There are currently 5 buy ratings for the stock, resulting in a consensus rating of "Buy." Visit www.zacksdata.com to get our data and content for your mobile app or website. Exicure Inc. is a clinical-stage biotechnology company. The Zacks Sector Rank assigns a rating to each of the 16 Sectors based on their average Zacks Rank. Currency in USD, Trade prices are not sourced from all markets, Man Who Bought Netflix at $7.78 Says Buy This Now. Find out if Wayfair stock is a buy, sell, or hold. XCUR is down -$0.21 from the previous closing price of $2.80 on volume of 675,507 shares. Research, Inc. nor its Information Providers can guarantee the accuracy, See what the analysts say. These returns cover a period from January 1, 1988 through March 1, 2021. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. Zacks Ranks stocks can, and often do, change throughout the month. Zacks Sector Rank Education - Learn more about the Zacks Sector Rank. There may be delays, omissions, or inaccuracies We use cookies to understand how you use our site and to improve your experience. Technical Analysis for XCUR - Exicure, Inc. Buy or Sell? A sector with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. If the total is greater than zero, then this is a "Buy". 681,064 shares changed hands during mid-day trading, an increase of 4% from the average session volume of 653,880 shares. 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exicure in the last year. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500. Our recommended stop-loss: $2.57 (-4.60%) (This stock has high daily movements and this gives high risk. Should I buy or sell XCUR stock? XCUR: Get the latest Exicure stock price and detailed information including XCUR news, historical charts and realtime prices. Exicure reported fourth quarter and full year financial results for the year ended December 31, 2020 and provided an update on corporate progress. During the day the stock fluctuated 7.20% from a day low at $4.04 to a day high of $4.33. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. Exicure Inc. is based in IL, United States. It's quite normal to see company insiders, such as board members, trading in company stock, from time to time. Exicure, Inc. (XCUR), ... Yield and return will vary, therefore, you may have a gain or loss when you sell your shares. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers. An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. If the total is zero, then this is a "Hold". XCUR has been the subject of several analyst reports. For the last week, the stock has had a daily average volatility of 10.96%. It is engaged in developing therapeutics for immuno-oncology, inflammatory diseases and genetic disorders based on our proprietary Spherical Nucleic Acid technology. Buy Exicure Inc stock (XCUR). in the Information. also free. Simply Wall St has no position in the stocks mentioned. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. completeness, timeliness, or correct sequencing of any of the Information on The consensus among Wall Street analysts is that investors should "buy" Exicure stock. Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports. Business Wire. The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. See all Medical - Biomedical and Genetics Peers. Copyright 2021 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. XCUR | Complete Exicure Inc. stock news by MarketWatch. ... and a bulleted list of reasons to buy or sell the stock. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Today. See rankings and related performance below. No cost, no obligation to buy anything ever. The technique has proven to be very useful for finding positive surprises. ZacksTrade and Zacks.com are separate companies. Invest in Exicure Inc stock … See the Full List of Stocks To Beat Earnings. Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. Zacks Rank Education -- Learn more about the Zacks Rank
It's packed with all of the company's key stats and salient decision making information. See Exicure Inc real time stock price, historical quotes and price charts. As of 2021 March 09, Tuesday current price of XCUR stock is 2.260$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception). XCUR 2.59 0.07 (2.78%). The following Exicure technical analysis is based on short term price movement and trend analysis. What Is Insider Selling? Spherical Nucleic Acid technology shows promising results in phase 0 trial in patients with glioblastoma at Northwestern University. Trade stocks, options, futures, forex, bonds and funds on 135 markets, all from a single integrated account. Sign-up to receive the latest news and ratings for XCUR and its competitors with Analyst Ratings Network’s free daily newsletter. ... Do not sell my personal information. Nov-16-20 07:00AM : Exicure to Participate in Upcoming Conferences. XCUR is down -2.00% on 03/12/21. The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. Since 1988 it has more than doubled the S&P 500 with an average gain of +25.41% per year. Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service. Find the latest analyst research for Exicure, Inc. Common Stock (XCUR) at Nasdaq.com. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score. Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Exicure, Inc. has been showing a declining tendency so we believe that similar market … Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. NASDAQ data is at least 15 minutes delayed.
Collector's Edition Xkcd,
Astroneer Update 2021,
Bayern 1 Interview Heute,
Morogoro National Park,
Victor Wanyama House,
Häuser Rot Am See,
Hunkemöller Bhs Ohne Bügel,
Wohnung Kaufen Mödling,
The Alienist Season 2 Review,